Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Number of Reporting Units

2.8 / 5 stars · 68/120 Roast Me

AKEBIA THERAPEUTICS, INC. Number of Reporting Units

AKEBIA THERAPEUTICS, INC. (AKBA) reported Number of Reporting Units of 1 reporting_unit for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Notes

us-gaap:NumberOfReportingUnits · last filed 2026-02-26

  • AKEBIA THERAPEUTICS, INC. number of reporting units for fiscal 2025 was 1.00 reporting_unit, a 0.00% change from fiscal 2024.
  • AKEBIA THERAPEUTICS, INC. number of reporting units for fiscal 2024 was 1.00 reporting_unit, a 0.00% change from fiscal 2023.
  • AKEBIA THERAPEUTICS, INC. number of reporting units for fiscal 2023 was 1.00 reporting_unit.
Period endNumber of Reporting Units 12 month
2025-12-311.00 reporting_unit
10-K · filed 2026-02-26
2024-12-311.00 reporting_unit
10-K · filed 2025-03-13
2023-12-311.00 reporting_unit
10-K · filed 2024-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33